Jinghui Dong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jinghui Dong has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Jianming Cai
Department of Radiology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
7 shared publications - Changchun Liu
Department of Radiology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
5 shared publications - Mengmeng Zhang
Department of Radiology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
5 shared publications - Xu Bai
Department of Radiology, First Medical Center Chinese PLA General Hospital Beijing China
5 shared publications - Yuan Liu
Medical School of Chinese PLA; Beijing China
4 shared publications - Di Zhao
Senior Department of Hepatology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China
3 shared publications
Latest Publications
- Open Access
- 31 January 2026
- Published by Wiley in Case Reports in Hepatology
- Vol. 2026 (1)
Two Cases of Hepatic Epithelioid Hemangioendothelioma Misdiagnosed With Hepatic Veno‐Occlusive Disease
Hepatic epithelioid hemangioendothelioma (HEHE) is a rare tumor of vascular origin with an incidence of < 0.1/100,000. The disease is easily misdiagnosed. The aim of this article is to increase public awareness and vigilance of HEHE. We report two cases presenting with fever, abdominal discomfort, abnormal liver function, and jaundice. Computed tomography (CT) and magnetic resonance imaging (MRI) of the abdomen suggested hepatic stasis, venous compression, and ascites, and liver biopsy was initially misdiagnosed as hepatic veno‐occlusive disease (VOD), which did not improve with treatment. In the first case, a male patient, after liver transplantation, pathological and immunohistochemical (IHC) analyses revealed hyperplasia of blood vessels in the liver tissue with dilated lumen and heterogeneous cells. Immunohistochemistry was performed and showed CD34 positivity, confirming the diagnosis of HEHE. The second female patient had liver bruising and ascites on imaging, and the first hepatic puncture was reported to be VOD, which did not improve with treatment. Repeat hepatic puncture was performed, and the diagnosis of HEHE was confirmed after a second repathology with additional immunohistochemistry for HEHE. These misdiagnosis cases highlight the challenge of diagnosing HEHE. This is the first report of misdiagnosis of HEHE as VOD. This article analyzes the underlying causes of misdiagnosis of HEHE and emphasizes the causes of imaging misdiagnosis and the importance of repeated hepatic puncture biopsy and immunohistochemistry in the diagnosis of HEHE.
- 31 January 2026
- Published by Wiley in Case Reports in Hepatology
- Vol. 2026 (1)
Open AccessTwo Cases of Hepatic Epithelioid Hemangioendothelioma Misdiagnosed With Hepatic Veno‐Occlusive Disease
Hepatic epithelioid hemangioendothelioma (HEHE) is a rare tumor of vascular origin with an incidence of < 0.1/100,000. The disease is easily misdiagnosed. The aim of this article is to increase public awareness and vigilance of HEHE. We report two cases presenting with fever, abdominal discomfort, abnormal liver function, and jaundice. Computed tomography (CT) and magnetic resonance imaging (MRI) of the abdomen suggested hepatic stasis, venous compression, and ascites, and liver biopsy was initially misdiagnosed as hepatic veno‐occlusive disease (VOD), which did not improve with treatment. In the first case, a male patient, after liver transplantation, pathological and immunohistochemical (IHC) analyses revealed hyperplasia of blood vessels in the liver tissue with dilated lumen and heterogeneous cells. Immunohistochemistry was performed and showed CD34 positivity, confirming the diagnosis of HEHE. The second female patient had liver bruising and ascites on imaging, and the first hepatic puncture was reported to be VOD, which did not improve with treatment. Repeat hepatic puncture was performed, and the diagnosis of HEHE was confirmed after a second repathology with additional immunohistochemistry for HEHE. These misdiagnosis cases highlight the challenge of diagnosing HEHE. This is the first report of misdiagnosis of HEHE as VOD. This article analyzes the underlying causes of misdiagnosis of HEHE and emphasizes the causes of imaging misdiagnosis and the importance of repeated hepatic puncture biopsy and immunohistochemistry in the diagnosis of HEHE.
- Open Access
- 18 January 2026
- Published by Elsevier in European Journal of Radiology Open
- Vol. 16, 100730
The value of virtual non-contrast images derived from dual-energy spectral CT in the short-term efficacy assessment of hepatocellular carcinoma after TACE
- 18 January 2026
- Published by Elsevier in European Journal of Radiology Open
- Vol. 16, 100730
Open AccessThe value of virtual non-contrast images derived from dual-energy spectral CT in the short-term efficacy assessment of hepatocellular carcinoma after TACE
- 27 September 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (5) , 2328-2340
Development of a clinical-CT-radiomics nomogram for predicting endoscopic red color sign in cirrhotic patients with esophageal varices
Purpose To evaluate the predictive performance of a clinical-CT-radiomics nomogram based on radiomics signature and independent clinical-CT predictors for predicting endoscopic red color sign (RC) in cirrhotic patients with esophageal varices (EV). Methods We retrospectively evaluated 215 cirrhotic patients. Among them, 108 and 107 cases were positive and negative for endoscopic RC, respectively. Patients were assigned to a training cohort (n = 150) and a validation cohort (n = 65) at a 7:3 ratio. In the training cohort, univariate and multivariate logistic regression analyses were performed on clinical and CT features to develop a clinical-CT model. Radiomic features were extracted from portal venous phase CT images to generate a Radiomic score (Rad-score) and to construct five machine learning models. A combined model was built using clinical-CT predictors and Rad-score through logistic regression. The performance of different models was evaluated using the receiver operating characteristic (ROC) curves and the area under the curve (AUC). Results The spleen-to-platelet ratio, liver volume, splenic vein diameter, and superior mesenteric vein diameter were independent predictors. Six radiomics features were selected to construct five machine learning models. The adaptive boosting model showed excellent predictive performance, achieving an AUC of 0.964 in the validation cohort, while the combined model achieved the highest predictive accuracy with an AUC of 0.985 in the validation cohort. Conclusion The clinical-CT-radiomics nomogram demonstrates high predictive accuracy for endoscopic RC in cirrhotic patients with EV, which provides a novel tool for non-invasive prediction of esophageal varices bleeding. Graphical Abstract
- 27 September 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (5) , 2328-2340
Development of a clinical-CT-radiomics nomogram for predicting endoscopic red color sign in cirrhotic patients with esophageal varices
Purpose To evaluate the predictive performance of a clinical-CT-radiomics nomogram based on radiomics signature and independent clinical-CT predictors for predicting endoscopic red color sign (RC) in cirrhotic patients with esophageal varices (EV). Methods We retrospectively evaluated 215 cirrhotic patients. Among them, 108 and 107 cases were positive and negative for endoscopic RC, respectively. Patients were assigned to a training cohort (n = 150) and a validation cohort (n = 65) at a 7:3 ratio. In the training cohort, univariate and multivariate logistic regression analyses were performed on clinical and CT features to develop a clinical-CT model. Radiomic features were extracted from portal venous phase CT images to generate a Radiomic score (Rad-score) and to construct five machine learning models. A combined model was built using clinical-CT predictors and Rad-score through logistic regression. The performance of different models was evaluated using the receiver operating characteristic (ROC) curves and the area under the curve (AUC). Results The spleen-to-platelet ratio, liver volume, splenic vein diameter, and superior mesenteric vein diameter were independent predictors. Six radiomics features were selected to construct five machine learning models. The adaptive boosting model showed excellent predictive performance, achieving an AUC of 0.964 in the validation cohort, while the combined model achieved the highest predictive accuracy with an AUC of 0.985 in the validation cohort. Conclusion The clinical-CT-radiomics nomogram demonstrates high predictive accuracy for endoscopic RC in cirrhotic patients with EV, which provides a novel tool for non-invasive prediction of esophageal varices bleeding. Graphical Abstract
- Open Access
- 4 December 2024
- Published by Springer Nature in Research Square
Evaluation of response to Targeted therapy and immunotherapy for advanced HCCs: A retrospective, controlled study
Background: To validate the correlation between radiomics extracted from magnetic resonance imaging (MRI) and pathologic alterations in advanced hepatocellular carcinoma (HCC) treated with targeted therapy and immunotherapy, and to compare the accuracy of necrosis evaluation by radiologists and subtraction technology. Methods: Thirty-five patients diagnosed unresectable HCCs (n = 39) who underwent curative resection at two centers after receiving combined treatment with tyrosine kinase inhibitors and programmed death ligand-1 antibodies were included. Using linear regression model to verify the consistency between investigator-based imaging evaluation and three-dimensional (3D) subtraction-based imaging analysis and their capability to distinguish major pathological response (MPR) and pathological complete remission (PCR) were compared using receiver operating characteristic (ROC) curve analysis with pathological outcome as the gold standard.The sensitivity, specificity, and area under the ROC curve (AUC) were compared. Results: 3D subtraction-based imaging analysis suggested a strong correlation with histopathologic alteration (R2 = 0.81) and was superior in classifying MPR or PCR comparing to the use of investigator-based imaging evaluation (area under the receiver operator characteristic curve: MRP, 0.80 vs. 0.52; PCR, 0.69 vs. 0.54). Conclusion: 3D subtraction-based imaging analysis based on tumor characteristics showed a stronger correlation with pathology, and 3D subtraction-based imaging analysis was significantly superior to investigator-based imaging evaluation in classifying MPR or PCR.
- 4 December 2024
- Published by Springer Nature in Research Square
Open AccessEvaluation of response to Targeted therapy and immunotherapy for advanced HCCs: A retrospective, controlled study
Background: To validate the correlation between radiomics extracted from magnetic resonance imaging (MRI) and pathologic alterations in advanced hepatocellular carcinoma (HCC) treated with targeted therapy and immunotherapy, and to compare the accuracy of necrosis evaluation by radiologists and subtraction technology. Methods: Thirty-five patients diagnosed unresectable HCCs (n = 39) who underwent curative resection at two centers after receiving combined treatment with tyrosine kinase inhibitors and programmed death ligand-1 antibodies were included. Using linear regression model to verify the consistency between investigator-based imaging evaluation and three-dimensional (3D) subtraction-based imaging analysis and their capability to distinguish major pathological response (MPR) and pathological complete remission (PCR) were compared using receiver operating characteristic (ROC) curve analysis with pathological outcome as the gold standard.The sensitivity, specificity, and area under the ROC curve (AUC) were compared. Results: 3D subtraction-based imaging analysis suggested a strong correlation with histopathologic alteration (R2 = 0.81) and was superior in classifying MPR or PCR comparing to the use of investigator-based imaging evaluation (area under the receiver operator characteristic curve: MRP, 0.80 vs. 0.52; PCR, 0.69 vs. 0.54). Conclusion: 3D subtraction-based imaging analysis based on tumor characteristics showed a stronger correlation with pathology, and 3D subtraction-based imaging analysis was significantly superior to investigator-based imaging evaluation in classifying MPR or PCR.
- Open Access
- 16 October 2024
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 11, 1466807
Association between composite dietary antioxidant index and fatty liver index among US adults
Background: The potential beneficial health effects of dietary antioxidants have been reported. However, the association of a composite dietary antioxidant index (CDAI) with fatty liver index (FLI) remains unclear. This study aims to assess whether CDAI (including its components) is associated with FLI among US adults.Methods: This population-based cross-sectional study used data on US adults from the National Health and Nutrition Examination Survey (NHANES) 2007–2018 cycles. Weighted generalized linear regression models were used to analyze the association between CDAI (including vitamin A, C, E, zinc, selenium, and carotenoids) and FLI, which was calculated by using body mass index (BMI), waist circumference and levels of γ-glutamyl transferase and triglycerides.Results: Weighted generalized linear regression models showed an inverse association between CDAI and FLI in the total population (β, −0.40; 95% CI, −0.59, −0.21), in women (β, −0.56; 95% CI, −0.94, −0.18), and in men (β, −0.32; 95% CI, −0.54, −0.10) after adjusting for various confounders. The restricted cubic splines showed the negative linear dose–response associations between CDAI and FLI (all P non_linear >0.05). The dietary selenium intake in women has an inverse U-shaped relationship with FLI, with an inflection point value of 110 μg. In model 3, intake of dietary antioxidants Vitamins A, C, E, and carotenoids were significantly negatively associated with FLI in female but only were vitamins A and E negatively associated with FLI in male. In subgroup analysis, CDAI showed a significantly negative relation to FLI among those aged 60 years or older (β, −0.57; 95% CI, −0.81, −0.33), among those who engaged in active physical activity (β, −0.46; 95% CI, −0.63, −0.29), among those without metabolic syndrome (β, −0.43; 95% CI, −0.62, −0.24), and those without hyperuricemia (β, −0.43; 95% CI, −0.60, −0.26). Additionally, CDAI was significantly negatively associated with male FLI, regardless of whether they had diabetes or not.Conclusion: In conclusion, our results indicate that higher CDAI may be associated with a lower FLI.
- 16 October 2024
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 11, 1466807
Open AccessAssociation between composite dietary antioxidant index and fatty liver index among US adults
Background: The potential beneficial health effects of dietary antioxidants have been reported. However, the association of a composite dietary antioxidant index (CDAI) with fatty liver index (FLI) remains unclear. This study aims to assess whether CDAI (including its components) is associated with FLI among US adults.Methods: This population-based cross-sectional study used data on US adults from the National Health and Nutrition Examination Survey (NHANES) 2007–2018 cycles. Weighted generalized linear regression models were used to analyze the association between CDAI (including vitamin A, C, E, zinc, selenium, and carotenoids) and FLI, which was calculated by using body mass index (BMI), waist circumference and levels of γ-glutamyl transferase and triglycerides.Results: Weighted generalized linear regression models showed an inverse association between CDAI and FLI in the total population (β, −0.40; 95% CI, −0.59, −0.21), in women (β, −0.56; 95% CI, −0.94, −0.18), and in men (β, −0.32; 95% CI, −0.54, −0.10) after adjusting for various confounders. The restricted cubic splines showed the negative linear dose–response associations between CDAI and FLI (all P non_linear >0.05). The dietary selenium intake in women has an inverse U-shaped relationship with FLI, with an inflection point value of 110 μg. In model 3, intake of dietary antioxidants Vitamins A, C, E, and carotenoids were significantly negatively associated with FLI in female but only were vitamins A and E negatively associated with FLI in male. In subgroup analysis, CDAI showed a significantly negative relation to FLI among those aged 60 years or older (β, −0.57; 95% CI, −0.81, −0.33), among those who engaged in active physical activity (β, −0.46; 95% CI, −0.63, −0.29), among those without metabolic syndrome (β, −0.43; 95% CI, −0.62, −0.24), and those without hyperuricemia (β, −0.43; 95% CI, −0.60, −0.26). Additionally, CDAI was significantly negatively associated with male FLI, regardless of whether they had diabetes or not.Conclusion: In conclusion, our results indicate that higher CDAI may be associated with a lower FLI.
- 21 September 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (3) , 1189-1197
Magnetic resonance imaging and clinicopathological findings of primary hepatic angiosarcoma
Purpose To investigate the magnetic resonance imaging (MRI) and clinicopathological features of primary hepatic angiosarcoma (PHA) and enhance preoperative diagnosis. Methods MRI and clinicopathological information of 12 cases proved PHA were reviewed. Summarize the MRI characteristics of PHA combined with literature reviews. Results Among 12 cases (6 males and 6 females; age range, 23–70 years; mean, 53.3 years), one presented as a large mass, two as a diffuse infiltrating tumor, and nine as a mixed pattern of large masses with multiple nodules, all involving both lobes of the liver and ranging from 0.1 cm to 11 cm in diameter. A total of 63 lesions were analyzed, including 21 masses and 42 nodules. 13 masses (61.9%) demonstrated intratumoral hemorrhage. 18 masses (85.7%) demonstrated heterogeneous patchy, ring-shaped, septate, or irregular shaped enhancing foci on late arterial phase (LAP). On dynamic contrast-enhanced MRI (DCE-MRI), 14 masses (66.7%) showed a centripetal or centrifugal pattern of incomplete progressive enhancement. 6 nodules (14.3%) appeared intratumoral hemorrhage. 31 nodules (73.8%) showed no enhancing foci on LAP images and 27 nodules (64.3%) showed enhancement pattern of complete filling, either centripetal or centrifugal pattern. Moreover, 12 cases (100%) exhibited prominent vessels within or adjacent to at least one lesion. Conclusion PHA exhibits diverse appearances on MRI. Typical MRI signs include multifoci with intratumoral hemorrhage, prominent vessels within or adjacent to the foci, as well as varied degrees of progressive enhancement with incomplete filling in dominant masses of PHA.
- 21 September 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (3) , 1189-1197
Magnetic resonance imaging and clinicopathological findings of primary hepatic angiosarcoma
Purpose To investigate the magnetic resonance imaging (MRI) and clinicopathological features of primary hepatic angiosarcoma (PHA) and enhance preoperative diagnosis. Methods MRI and clinicopathological information of 12 cases proved PHA were reviewed. Summarize the MRI characteristics of PHA combined with literature reviews. Results Among 12 cases (6 males and 6 females; age range, 23–70 years; mean, 53.3 years), one presented as a large mass, two as a diffuse infiltrating tumor, and nine as a mixed pattern of large masses with multiple nodules, all involving both lobes of the liver and ranging from 0.1 cm to 11 cm in diameter. A total of 63 lesions were analyzed, including 21 masses and 42 nodules. 13 masses (61.9%) demonstrated intratumoral hemorrhage. 18 masses (85.7%) demonstrated heterogeneous patchy, ring-shaped, septate, or irregular shaped enhancing foci on late arterial phase (LAP). On dynamic contrast-enhanced MRI (DCE-MRI), 14 masses (66.7%) showed a centripetal or centrifugal pattern of incomplete progressive enhancement. 6 nodules (14.3%) appeared intratumoral hemorrhage. 31 nodules (73.8%) showed no enhancing foci on LAP images and 27 nodules (64.3%) showed enhancement pattern of complete filling, either centripetal or centrifugal pattern. Moreover, 12 cases (100%) exhibited prominent vessels within or adjacent to at least one lesion. Conclusion PHA exhibits diverse appearances on MRI. Typical MRI signs include multifoci with intratumoral hemorrhage, prominent vessels within or adjacent to the foci, as well as varied degrees of progressive enhancement with incomplete filling in dominant masses of PHA.
- Open Access
- 12 August 2024
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 15 (1) , 102403
Prediction Modelling for Gastroesophageal Variceal Bleeding in Patients With Chronic Hepatitis B Using Four-dimensional Flow MRI
- 12 August 2024
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 15 (1) , 102403
Open AccessPrediction Modelling for Gastroesophageal Variceal Bleeding in Patients With Chronic Hepatitis B Using Four-dimensional Flow MRI
- Open Access
- 26 April 2024
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 20, 1-7
4D Flow MRI of Portal Vein Hemodynamics in Healthy Volunteers and Patients with Chronic Liver Disease
Aim:: To identify age-matched healthy volunteers, non-cirrhotic chronic liver disease (CLD) and cirrhotic patients based on portal hemodynamic parameters using 4D flow MRI. Methods:: A total of 10 age-matched healthy volunteers and 69 CLD patients were enrolled and underwent 4D flow MRI prospectively. 4D flow MR images were processed by an MD in biomedical engineering working on the GTFlow platform. Portal hemodynamic parameters include net flow (mL/cycle), flow volume per second through the lumen (mL/sec), average flow velocity (cm/sec), and maximum flow velocity (cm/sec). The difference in portal hemodynamic parameters of 4D flow MRI was compared among healthy volunteers, non-cirrhotic CLD patients and patients with cirrhosis by one-way ANOVA or Kruskal-Wallis nonparametric test and post hoc tests. Results:: 10 CLD patients without cirrhosis and 56 patients with cirrhosis were eventually included, along with 10 healthy volunteers who were divided into three groups. 3 patients with cirrhosis whose image quality did not meet the requirements were excluded. There were no significant differences in portal hemodynamic parameters among the three groups except portal average velocity (P > 0.05). There was no statistical difference in all portal hemodynamic parameters of 4D flow MRI between healthy volunteers and patients with cirrhosis (P > 0.05). There were significant differences in portal average velocity between non-cirrhotic CLD patients, healthy volunteers and patients with cirrhosis, respectively (11.44±3.93 vs 8.10±2.66, P=0.013; 11.44±3.93 vs 8.60±2.22, P=0.007). Conclusion:: Portal average velocity obtained by 4D flow MRI can be an auxiliary means to identify cirrhosis in patients with CLD.
- 26 April 2024
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 20, 1-7
Open Access4D Flow MRI of Portal Vein Hemodynamics in Healthy Volunteers and Patients with Chronic Liver Disease
Aim:: To identify age-matched healthy volunteers, non-cirrhotic chronic liver disease (CLD) and cirrhotic patients based on portal hemodynamic parameters using 4D flow MRI. Methods:: A total of 10 age-matched healthy volunteers and 69 CLD patients were enrolled and underwent 4D flow MRI prospectively. 4D flow MR images were processed by an MD in biomedical engineering working on the GTFlow platform. Portal hemodynamic parameters include net flow (mL/cycle), flow volume per second through the lumen (mL/sec), average flow velocity (cm/sec), and maximum flow velocity (cm/sec). The difference in portal hemodynamic parameters of 4D flow MRI was compared among healthy volunteers, non-cirrhotic CLD patients and patients with cirrhosis by one-way ANOVA or Kruskal-Wallis nonparametric test and post hoc tests. Results:: 10 CLD patients without cirrhosis and 56 patients with cirrhosis were eventually included, along with 10 healthy volunteers who were divided into three groups. 3 patients with cirrhosis whose image quality did not meet the requirements were excluded. There were no significant differences in portal hemodynamic parameters among the three groups except portal average velocity (P > 0.05). There was no statistical difference in all portal hemodynamic parameters of 4D flow MRI between healthy volunteers and patients with cirrhosis (P > 0.05). There were significant differences in portal average velocity between non-cirrhotic CLD patients, healthy volunteers and patients with cirrhosis, respectively (11.44±3.93 vs 8.10±2.66, P=0.013; 11.44±3.93 vs 8.60±2.22, P=0.007). Conclusion:: Portal average velocity obtained by 4D flow MRI can be an auxiliary means to identify cirrhosis in patients with CLD.
- Open Access
- 1 September 2023
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 47 (5) , 729-737
Predicting Breast Cancer Subtypes Using Magnetic Resonance Imaging Based Radiomics With Automatic Segmentation
Objective: The aim of the study is to demonstrate whether radiomics based on an automatic segmentation method is feasible for predicting molecular subtypes. Methods: This retrospective study included 516 patients with confirmed breast cancer. An automatic segmentation—3-dimensional UNet-based Convolutional Neural Networks, trained on our in-house data set—was applied to segment the regions of interest. A set of 1316 radiomics features per region of interest was extracted. Eighteen cross-combination radiomics methods—with 6 feature selection methods and 3 classifiers—were used for model selection. Model classification performance was assessed using the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, and specificity. Results: The average dice similarity coefficient value of the automatic segmentation was 0.89. The radiomics models were predictive of 4 molecular subtypes with the best average: AUC = 0.8623, accuracy = 0.6596, sensitivity = 0.6383, and specificity = 0.8775. For luminal versus nonluminal subtypes, AUC = 0.8788 (95% confidence interval [CI], 0.8505–0.9071), accuracy = 0.7756, sensitivity = 0.7973, and specificity = 0.7466. For human epidermal growth factor receptor 2 (HER2)–enriched versus non-HER2–enriched subtypes, AUC = 0.8676 (95% CI, 0.8370–0.8982), accuracy = 0.7737, sensitivity = 0.8859, and specificity = 0.7283. For triple-negative breast cancer versus non–triple-negative breast cancer subtypes, AUC = 0.9335 (95% CI, 0.9027–0.9643), accuracy = 0.9110, sensitivity = 0.4444, and specificity = 0.9865. Conclusions: Radiomics based on automatic segmentation of magnetic resonance imaging can predict breast cancer of 4 molecular subtypes noninvasively and is potentially applicable in large samples.
- 1 September 2023
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 47 (5) , 729-737
Open AccessPredicting Breast Cancer Subtypes Using Magnetic Resonance Imaging Based Radiomics With Automatic Segmentation
Objective: The aim of the study is to demonstrate whether radiomics based on an automatic segmentation method is feasible for predicting molecular subtypes. Methods: This retrospective study included 516 patients with confirmed breast cancer. An automatic segmentation—3-dimensional UNet-based Convolutional Neural Networks, trained on our in-house data set—was applied to segment the regions of interest. A set of 1316 radiomics features per region of interest was extracted. Eighteen cross-combination radiomics methods—with 6 feature selection methods and 3 classifiers—were used for model selection. Model classification performance was assessed using the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, and specificity. Results: The average dice similarity coefficient value of the automatic segmentation was 0.89. The radiomics models were predictive of 4 molecular subtypes with the best average: AUC = 0.8623, accuracy = 0.6596, sensitivity = 0.6383, and specificity = 0.8775. For luminal versus nonluminal subtypes, AUC = 0.8788 (95% confidence interval [CI], 0.8505–0.9071), accuracy = 0.7756, sensitivity = 0.7973, and specificity = 0.7466. For human epidermal growth factor receptor 2 (HER2)–enriched versus non-HER2–enriched subtypes, AUC = 0.8676 (95% CI, 0.8370–0.8982), accuracy = 0.7737, sensitivity = 0.8859, and specificity = 0.7283. For triple-negative breast cancer versus non–triple-negative breast cancer subtypes, AUC = 0.9335 (95% CI, 0.9027–0.9643), accuracy = 0.9110, sensitivity = 0.4444, and specificity = 0.9865. Conclusions: Radiomics based on automatic segmentation of magnetic resonance imaging can predict breast cancer of 4 molecular subtypes noninvasively and is potentially applicable in large samples.